(A) determining how to improve research 
and health care programs; 
(B) identifying any gaps in the overall re-
search inventory and in health care programs; 
(C) identifying opportunities to promote 
translation of research into practice; and 
(D) maximizing the effects of Federal ef-
forts by identifying opportunities for collabora-
tion and leveraging of resources in research and 
health care programs that serve those suscep-
tible to or diagnosed with prostate cancer; 
(4) develop a comprehensive interagency strat-
egy and advise relevant Federal agencies in the solic-
itation of proposals for collaborative, multidisci-
plinary research and health care programs, including 
proposals to evaluate factors that may be related to 
the etiology of prostate cancer, that would— 
(A) result in innovative approaches to 
study emerging scientific opportunities or elimi-
nate knowledge gaps in research; 
(B) outline key research questions, meth-
odologies, and knowledge gaps; 
(C) ensure consistent action, as outlined by 
section 402(b) of the Public Health Service Act; 
VerDate Mar 15 2010 
03:30 Oct 13, 2010
Jkt 099200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H6389.IH
H6389
erowe on DSKB9S0YB1PROD with BILLS
(5) develop a coordinated message related to 
screening and treatment for prostate cancer to be 
reflected in educational and beneficiary materials for 
Federal health programs as such documents are up-
dated; and 
(6) not later than two years after the date of 
the establishment of the Prostate Cancer Task 
Force, submit to the Secretary of Veterans Affairs 
recommendations— 
(A) regarding any appropriate changes to 
research and health care programs, including 
recommendations to improve the research port-
folio of the Department of Veterans Affairs, 
Department of Defense, National Institutes of 
Health, and other Federal agencies to ensure 
that scientifically based strategic planning is 
implemented in support of research and health 
care program priorities; 
(B) designed to ensure that the research 
and health care programs and activities of the 
Department of Veterans Affairs, the Depart-
ment of Defense, the Department of Health and 
Human Services, and other Federal agencies 
are free of unnecessary duplication; 
VerDate Mar 15 2010 
00:58 Oct 13, 2010
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H6389.IH
H6389
erowe on DSKB9S0YB1PROD with BILLS
(C) regarding public participation in deci-
sions relating to prostate cancer research and 
health care programs to increase the involve-
ment of patient advocates, community organiza-
tions, and medical associations representing a 
broad geographical area; 
(D) on how to best disseminate informa-
tion on prostate cancer research and progress 
achieved by health care programs; 
(E) about how to expand partnerships be-
tween public entities, including Federal agen-
cies, and private entities to encourage collabo-
rative, cross-cutting research and health care 
delivery; 
(F) assessing any cost savings and effi-
ciencies realized through the efforts identified 
and supported in this Act and recommending 
expansion of those efforts that have proved 
most promising while also ensuring against any 
conflicts in directives from other congressional 
or statutory mandates or enabling statutes; 
(G) identifying key priority action items 
from among the recommendations; and 
VerDate Mar 15 2010 
00:58 Oct 13, 2010
Jkt 099200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H6389.IH
H6389
erowe on DSKB9S0YB1PROD with BILLS
(H) with respect to the level of funding 
needed by each agency to implement the rec-
ommendations contained in the report. 
(c) MEMBERS
OF
THE PROSTATE CANCER TASK 
FORCE.—The Prostate Cancer Task Force described in 
subsection (a) shall be composed of representatives from 
such Federal agencies, as each Secretary determines nec-
essary, to coordinate a uniform message relating to pros-
tate cancer screening and treatment where appropriate, 
including representatives of the following: 
(1) The Department of Veterans Affairs, in-
cluding representatives of each relevant program 
areas of the Department of Veterans Affairs. 
(2) The Prostate Cancer Research Program of 
the Congressionally Directed Medical Research Pro-
gram of the Department of Defense. 
(3) The Department of Health and Human 
Services. 
(d) APPOINTING EXPERT ADVISORY PANELS.—The 
Prostate Cancer Task Force shall appoint expert advisory 
panels, as determined appropriate, to provide input and 
concurrence from individuals and organizations from the 
medical, research, and delivery communities with expertise 
in prostate cancer diagnosis, treatment, and research, in-
cluding practicing urologists, primary care providers, and 
VerDate Mar 15 2010 
00:58 Oct 13, 2010
Jkt 099200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H6389.IH
H6389
erowe on DSKB9S0YB1PROD with BILLS
others and individuals with expertise in education and out-
reach to underserved populations affected by prostate can-
cer. 
(e) MEETINGS.—The Prostate Cancer Task Force 
shall convene not less than twice a year, or more fre-
quently as the Secretary determines to be appropriate. 
(f) SUBMITTAL
OF RECOMMENDATIONS
TO CON-
GRESS.—The Secretary of Veterans Affairs shall submit 
to Congress any recommendations submitted to the Sec-
retary under subsection (b)(5). 
(g) FEDERAL ADVISORY COMMITTEE ACT.— 
(1) IN GENERAL.—Except as provided in para-
graph (2), the Federal Advisory Committee Act (5 
U.S.C. App.) shall apply to the Prostate Cancer 
Task Force. 
(2) EXCEPTION.—Section 14(a)(2)(B) of such 
Act (relating to the termination of advisory commit-
tees) shall not apply to the Prostate Cancer Task 
Force. 
SEC. 4. PROSTATE CANCER RESEARCH. 
(a) RESEARCH COORDINATION.—The Secretary of 
Veterans Affairs, in coordination with the Secretaries of 
Defense and of Health and Human Services, shall estab-
lish and carry out a program to coordinate and intensify 
VerDate Mar 15 2010 
00:58 Oct 13, 2010
Jkt 099200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H6389.IH
H6389
erowe on DSKB9S0YB1PROD with BILLS